Browsing by Grant Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中 >>

Browse by Funding Year 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Showing results 12 to 19 of 19

< previous

	Project Title	Principal Investigator	Year
12	International, randomized, open-label, phase 3, trial of paclitaxel/carboplatin plus PF-3512676 versus paclitaxel/carboplatin alone as first line treatment of patients with advanced non-small cell lung cancer	Ho, James Chung Man	2006/2007
13	Multicenter, randomized, double-blind, phase III trial to investigate the efficacy and safety of oral BIBF 1120 plus standard pemetrexed therapy compared to placebo plus standard pemetrexed therapy in patients with stage IIIB/IV or recurrent non small cell lung cancer after failure of first line chemotherapy	Ho, James Chung Man	2008/2009
14	Open label, prospective, double arm, randomized, pilot study to evaluate the safety and efficacy of the same day administration of PDT with verteporfin and an intravitreal injection of ranibizumab vs. ranibizumab monotherapy for the treatment of subfoveal CNV secondary to neovascular age related macular degeneration in the Asian population	Lai, Wai Kwan Wico	2007/2008
15	Phase 2, open-label single arm study of the efficacy and safety of PF 02341066 in patients with advanced non-small cell lung cancer (NSCLC) harboring a translocation or inversion involving the anaplastic lymphoma kinase (ALK) gene locus	Ho, James Chung Man	2010/2011
16	Phase 3, randomized, open-label study of the efficacy and safety of PF-02341066 versus standard of care chemotherapy (pemetrexed or docetaxel) in patients with advanced nonsmall cell lung cancer (NSCLC) harbouring a translocation or inversion event involving the anaplastic lymphoma kinase (ALK) gene locus	Ho, James Chung Man	2010/2011
17	Randomized controlled trial of S-1 versus docetaxel in patients with non-small cell lung cancer who have received a platinum-based treatment	Ho, James Chung Man	2010/2011
18	Randomized, Multicenter, Double-Blind, Phase 3 Trial Comparing the Efficacy of Ipilimumab in Addition to Paclitaxel and Carboplatin versus Placebo in Addition to Paclitaxel and Carboplatin in Subjects with Stage IV/Recurrent Non-Small Cell Lung Cancer (NSCLC)	Ho, James Chung Man	2010/2011
19	Study of immunopathogenesis of multiple sclerosis and neuromyelitis optica	Chan, Koon Ho	2011/2012

< previous